Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
33.30 MEUR
295.83 MEUR
11.43 M
About Eagle Pharmaceuticals, Inc.
Sector
CEO
Michael Graves
Headquarters
Woodcliff Lake
Website
Employees (FY)
135
Founded
2007
FIGI
BBG00645T0X2
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EAGLE PHARMACEUTI.DL-,001 stocks are traded under the ticker 1E6.
EAGLE PHARMACEUTI.DL-,001 is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track EAGLE PHARMACEUTI.DL-,001 financials in yearly and quarterly reports right on TradingView.
No, 1E6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1E6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EAGLE PHARMACEUTI.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
As of May 13, 2024, the company has 135.00 employees. See our rating of the largest employees — is EAGLE PHARMACEUTI.DL-,001 on this list?